RESEARCHER PROFILE

M. Ghazi

← Back to University of Fallujah

M

University of Fallujah

Bone health and osteoporosis researchRheumatoid Arthritis Research and TherapiesMenopause: Health Impacts and TreatmentsAutoimmune and Inflammatory Disorders ResearchBody Composition Measurement Techniques

M. Ghazi works in Bone health and osteoporosis research, Rheumatoid Arthritis Research and Therapies, Menopause: Health Impacts and Treatments, Autoimmune and Inflammatory Disorders Research, Body Composition Measurement Techniques. Recorded institutional associations include University of Fallujah.

55Publications
596Citations
9H-index

ORCID

Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.

Selected research works

Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.

  1. Prevalence and risk factors of osteoporosis and vertebral fractures in patients with ankylosing spondylitis

    2009 · 223 citations

  2. Prevalence of vertebral fractures in patients with rheumatoid arthritis: revisiting the role of glucocorticoids

    2011 · 99 citations

  3. Reproducibility of bone mineral density measurements using dual X-ray absorptiometry in daily clinical practice

    2005 · 90 citations

  4. Discordance Between Hip and Spine Bone Mineral Density Measurement Using DXA: Prevalence and Risk Factors

    2008 · 81 citations

  5. Vertebral fracture assessment in healthy men: Prevalence and risk factors

    2008 · 33 citations

  6. Bone mineral density of the spine and femur in a group of healthy Moroccan men

    2009 · 19 citations

  7. Performance of calcaneus quantitative ultrasound and dual-energy X-ray absorptiometry in the discrimination of prevalent asymptomatic osteoporotic fractures in postmenopausal women

    2008 · 18 citations

  8. Drug-induced lupus-like syndrome in ankylosing spondylitis treated with infliximab.

    2008 · 13 citations

  9. Bone turnover and hormonal perturbations in patients with fibromyalgia.

    2006 · 10 citations

  10. The“Back Book” translated to Arabic

    2018 · 3 citations

  11. Physiological Alterations in Local Iraqi Sheep Affected by Ruminal Impaction: Insights from Biochemical, Electrolyte, and Oxidative Markers

    2026 · 1 citations

  12. Dataset for the ruminal impaction in sheep (2025)

    2025 · 1 citations

  13. ABS0224 RITUXIMAB IN REAL LIFE: 3-YEAR DATA FROM THE BIOTHERAPY REGISTRY OF THE MOROCCAN SOCIETY OF RHEUMATOLOGY (RBSMR): A MULTICENTER STUDY

    2025 · 1 citations

  14. AB0444 SAFETY PROFILE OF BIOLOGICAL THERAPY IN RHEUMATOID ARTHRITIS IN MOROCCO. DATA FROM THE RBSMR

    2023 · 1 citations

  15. Contribution de la technique d’élution directe à la découverte d’une nouvelle allo-immunisation chez les patients transfusés présentant un TDA positif

    2014 · 1 citations

  16. Prévalence et facteurs de risque de fractures vertébrales chez les femmes marocaines ménopausées

    2007 · 1 citations

  17. Validation de l'indice de risque de l'ostéoporose OST (Osteoporosis Self-assessment Tool) chez les femmes ménopausées marocaines

    2006 · 1 citations

  18. Effects of Methandienone on the ovaries of rabbits in relation to the aromatase gene (CYP19A1) and oxidative markers and the possible protective role of selenium

    2026 · 0 citations

  19. Évaluation du fardeau et des facteurs associés chez les proches aidants de patients atteints de rhumatismes inflammatoires chroniques

    2025 · 0 citations

  20. Thérapies ciblées en monothérapie dans la polyarthrite rhumatoïde : efficacité et tolérance – étude prospective multicentrique

    2025 · 0 citations

  21. Real-World Use of Rituximab in Rheumatoid Arthritis: A 3-Year Analysis from the RBSMR Biologic Registry

    2025 · 0 citations

  22. Le Trabecular Bone Score : place dans l’évaluation du risque fracturaire ostéoporotique chez les patientes atteintes de polyarthrite rhumatoïde

    2024 · 0 citations

  23. Le risque infectieux sous anti-TNFα dans le registre de biothérapie de la Société marocaine de rhumatologie

    2021 · 0 citations

  24. Le rituximab dans la vraie vie : données du registre de biothérapie de la Société Marocaine de Rhumatologie, RBSMR

    2021 · 0 citations

  25. Efficacité des traitements biologiques en monothérapie ou en association à des traitements de fond conventionnels au cours de la polyarthrite rhumatoïde : registre RBSMR

    2020 · 0 citations

← Return to the university profile